← All news

Artificial Intelligence

Closing the data loop in AI-driven drug discovery

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law.

Read the full story on MIT Technology Review AI.

Read at source (opens in a new tab)

Latest from MIT Technology Review AI